Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
10
×
boulder/denver blog main
boulder/denver top stories
cancer
10
×
detroit blog main
detroit top stories
fda
10
×
indiana blog main
indiana top stories
life sciences
10
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
10
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
startups
clinical trials
eli lilly
cancer immunotherapy
deals
investing
pfizer
alzheimer's disease
bristol-myers squibb
incyte
ipo
What
roundup
10
×
bio
companies
drug
drugs
fda
life
science
week
ahead
annual
asco
attention
biotech
black
cancer
cash
days
diamond’s
growing
ipo
new
pharmaceutical
activity
alliance
alzheimer’s
ambien
american
appetite
approvals
approved
arena’s
assessed
attendees
bails
biogen
bounty
brand
branded
bread
Language
unset
Current search:
fda
×
roundup
×
" san diego top stories "
×
" boston top stories "
×
" life sciences "
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More